New pill could tame gut inflammation in colitis patients

NCT ID NCT07265570

Recruiting now Disease control Sponsor: InSilico Medicine Hong Kong Limited Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 12 times

Summary

This study tests a new drug called ISM5411 in 80 adults with active ulcerative colitis, a condition causing inflammation in the colon. Participants will receive either the drug or a placebo to see if it is safe and helps control symptoms. The goal is to manage the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Friendship Hospital, Capital Medical University
RECRUITING

Beijing, Beijing Municipality, China
Binzhou Medical University Hospital
RECRUITING

Binzhou, Shandong, China
First Hospital of Shanxi Medical University
RECRUITING

Taiyuan, Shanxi, China
Guangzhou First People's Hospital
RECRUITING

Guangzhou, Guangdong, China
Huizhou First Hospital
RECRUITING

Huizhou, Guangdong, China
Lishui Central Hospital
NOT_YET_RECRUITING

Lishui, Zhejiang, China
Longhua Hospital Shanghai University of Traditional Chinese Medicine
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, China
Meihekou Central Hospital
RECRUITING

Tonghua, Jilin, China
Renji Hospital, Shanghai Jiaotong University School of Medicine
RECRUITING

Shanghai, Shanghai Municipality, China
Renmin Hospital of Wuhan University
RECRUITING

Wuhan, Hubei, China
Shengjing Hospital of China Medical University
RECRUITING

Shenyang, Liaoning, China
Sichuan Provincial People's Hospital
RECRUITING

Chengdu, Sichuan, China
Tai 'an City Central Hospital
RECRUITING

Taian, Shandong, China
The First Affiliated Hospital of Chongqing Medical University
RECRUITING

Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Gannan Medical University
RECRUITING

Ganzhou, Jiangxi, China
The First Affiliated Hospital of Henan University of Science & Technology
RECRUITING

Luoyang, Henan, China
The First Affiliated Hospital of Kunming Medical University
RECRUITING

Kunming, Yunnan, China
The First Affiliated Hospital of University of South China
NOT_YET_RECRUITING

Hengyang, Hunan, China
The First Affiliated Hospital of Xinxiang Medical University
RECRUITING

Xinxiang, Henan, China
The First Affiliated Hospital,Sun Yat-sen University
RECRUITING

Guangzhou, Guangdong, China
The People's Hospital of Guangxi Zhuang Autonomous Region
RECRUITING

Nanning, Guangxi, China
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
RECRUITING

Wenzhou, Zhejiang, China
The Second Hospital of HeBei Medical University
RECRUITING

Shijiazhuang, Hebei, China
The Third Xiangya Hospital of Central South University
NOT_YET_RECRUITING

Changsha, Hunan, China
Tianjin People's Hospital
RECRUITING

Tianjin, Tianjin Municipality, China
West China School of Medicine and West China Hospital Sichuan University
RECRUITING

Chengdu, Sichuan, China
Xi'an Central Hospital
NOT_YET_RECRUITING

Xian, Shanxi, China
ZhongDa Hospital Southeast University
RECRUITING

Nanjing, Jiangsu, China

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS ULCERATIVE COLITIS